CN1246354A - Medicinal composition for treating hyperplasia of mammary gland disease - Google Patents
Medicinal composition for treating hyperplasia of mammary gland disease Download PDFInfo
- Publication number
- CN1246354A CN1246354A CN 99111548 CN99111548A CN1246354A CN 1246354 A CN1246354 A CN 1246354A CN 99111548 CN99111548 CN 99111548 CN 99111548 A CN99111548 A CN 99111548A CN 1246354 A CN1246354 A CN 1246354A
- Authority
- CN
- China
- Prior art keywords
- medicinal composition
- mammary gland
- radix
- pharmaceutical composition
- gland disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicinal composition for treating mastoplasia is prepared from 12 Chiense-medicinal materials including oyster shell, seaweed, laminaria, spatholobus stem, epimedium, etc. Its advantages include high effective rate up to 95.4%, and no toxic by-effect.
Description
The invention belongs to the drug matching preparation, be meant a kind of pharmaceutical composition for the treatment of cyclomastopathy especially.
Cyclomastopathy is a kind of commonly encountered diseases, frequently-occurring disease, often betide the 30-50 middle-aged women in year, adolescence and the women after menopause then send out this disease less, its pathogeneticing characteristic is that breast has lump, and with distending pain before the warp in various degree, belong to the traditional Chinese medical science " nodules of the breast " scope, this kind treatment of conditions exists the deficiency of existing medication effect difference clinically.
The object of the present invention is to provide a kind of pharmaceutical composition of cyclomastopathy for the treatment of to overcome the deficiency of prior art.
The composition of each drug component is (Unit Weight part, down together) among the present invention:
Herba Epimedii 8-12 Radix Salviae Miltiorrhizae 5.8-9
Radix Paeoniae Rubra 3-5 does not stay row (stir-fry) 5.8-9
Radix Bupleuri 3-6
The other drug group cellophane also has among the present invention:
Concha Ostreae (coarse powder) 15-23 Semen Cuscutae 8-12
Sargassum 8-12 Rhizoma Cyperi (vinegar system) 3-5
Thallus Laminariae (Thallus Eckloniae) 8-12 Pericarpium Citri Reticulatae Viride 3-5
Caulis Spatholobi 8-12
Below in conjunction with embodiment the present invention is further described:
Embodiment 1:
Each drug component composition is in the present embodiment:
Concha Ostreae (coarse powder) 15 Sargassums 8 Thallus Laminariae (Thallus Eckloniae)s 8
Caulis Spatholobi 8 Herba Epimedii 8 Semen Cuscutae 8
Semen Vaccariae (stir-fry) 5.8 Radix Salviae Miltiorrhizaes 5.8 Radix Bupleuri 3
Rhizoma Cyperi (vinegar system) 3 Radix Paeoniae Rubra 3 Pericarpium Citri Reticulatae Virides 3
Embodiment 2:
Concha Ostreae (coarse powder) 23 Sargassums 12 Thallus Laminariae (Thallus Eckloniae)s 12
Caulis Spatholobi 12 Herba Epimedii 12 Semen Cuscutae 12
Semen Vaccariae (stir-fry) 9 Radix Salviae Miltiorrhizaes 9 Radix Bupleuri 6
Rhizoma Cyperi (vinegar system) 5 Radix Paeoniae Rubra 5 Pericarpium Citri Reticulatae Virides 5
Each drug component effect is among the present invention:
Radix bupleuri: bitter, be slightly cold, soothing liver-qi stagnation, it is happy that the mechanism of qi bar is reached; Rhizoma cyperi, rascal enter Liver Channel, help the radix bupleuri dispersing stagnated hepatoqi and pain relieving; The red sage root, the seed of cowherb, the radix paeoniae rubrathe, reticulate millettia are established for stopping up resistance for blood block up breast network; The red sage root, Gu have saying of " red sage root loosing simply, the same Siwu Tang of merit ", can enrich blood; Invigorate blood circulation, be the common medicine of the disease of blood stasis; The seed of cowherb, kind promoting blood circulation, row and not staying rises and does not keep, logical newborn network and stagnation resolvation; Reticulate millettia can also can be enriched blood in promoting the circulation of qi; The radix paeoniae rubrathe is promoting blood flow and remove blood stasis pain relieving medicine commonly used, and above-mentioned four medicines share and can reach stagnation resolvation and the purpose of non-blood trouble. Oyster, marine alga, kelp are returned liver kidney two warps, play altogether dispelling phelgm to soften abdominal mass with the merit of the heavily fortified point that looses, with rascal, the qi-activating drug of rhizoma cyperi cooperates, the merit of its vanishing sputum and dispelling knot is stronger, barrenwort, the seed of Chinese dodder cooperate, and are intended to filling liver kidney, Gu Chong appoints, and the medicine-feeding compatibility gathers the merit of soothing liver-qi stagnation, regulating qi-flowing for relieving pain, mass dissipating and swelling eliminating altogether.
The obtained technological progress of the present invention is:
This compatibility of drugs is reasonable, has no side effect the efficient height of clinical treatment (reaching 95.4%).
Claims (2)
1, a kind of pharmaceutical composition for the treatment of cyclomastopathy, it is characterized in that wherein containing (Unit Weight part, down together) Herba Epimedii 8-12 Radix Salviae Miltiorrhizae 5.8-9 Radix Paeoniae Rubra 3-5 Semen Vaccariae (stir-fry) 5.8-9 Radix Bupleuri 3-6
2, pharmaceutical composition according to claim 1 is characterized in that wherein also having: Concha Ostreae (coarse powder) 15-23 Semen Cuscutae 8-12 Sargassum 8-12 Rhizoma Cyperi (vinegar system) 3-5 Thallus Laminariae (Thallus Eckloniae) 8-12 Pericarpium Citri Reticulatae Viride 3-5 Caulis Spatholobi 8-12
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99111548A CN1086131C (en) | 1999-08-20 | 1999-08-20 | Medicinal composition for treating hyperplasia of mammary gland disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99111548A CN1086131C (en) | 1999-08-20 | 1999-08-20 | Medicinal composition for treating hyperplasia of mammary gland disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1246354A true CN1246354A (en) | 2000-03-08 |
| CN1086131C CN1086131C (en) | 2002-06-12 |
Family
ID=5275152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99111548A Expired - Fee Related CN1086131C (en) | 1999-08-20 | 1999-08-20 | Medicinal composition for treating hyperplasia of mammary gland disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1086131C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1305512C (en) * | 2004-04-30 | 2007-03-21 | 北京荣昌药物研究院有限公司 | Traditional Chinese medicine compound recipe for treating hyperplasia of mammary glands and preparation method thereof |
| CN102579971A (en) * | 2011-10-20 | 2012-07-18 | 新乡市迪福康医药生物技术有限公司 | Chinese medicine preparation for curing hyperplasia of mammary glands |
| CN106109814A (en) * | 2016-08-29 | 2016-11-16 | 河北国金药业有限责任公司 | The preparation method of breast disease spirit granule |
| CN106214904A (en) * | 2016-08-29 | 2016-12-14 | 河北国金药业有限责任公司 | Pharmaceutical composition treats the application in the female endocrine dyscrasia medicine that depression of liver-QI causes as preparation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060085C (en) * | 1998-06-08 | 2001-01-03 | 信国峰 | 'Kangruling' medicine mixture |
-
1999
- 1999-08-20 CN CN99111548A patent/CN1086131C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1305512C (en) * | 2004-04-30 | 2007-03-21 | 北京荣昌药物研究院有限公司 | Traditional Chinese medicine compound recipe for treating hyperplasia of mammary glands and preparation method thereof |
| CN102579971A (en) * | 2011-10-20 | 2012-07-18 | 新乡市迪福康医药生物技术有限公司 | Chinese medicine preparation for curing hyperplasia of mammary glands |
| CN102579971B (en) * | 2011-10-20 | 2015-09-16 | 新乡市迪福康医药生物技术有限公司 | A kind of Chinese medicine preparation for the treatment of cyclomastopathy |
| CN106109814A (en) * | 2016-08-29 | 2016-11-16 | 河北国金药业有限责任公司 | The preparation method of breast disease spirit granule |
| CN106214904A (en) * | 2016-08-29 | 2016-12-14 | 河北国金药业有限责任公司 | Pharmaceutical composition treats the application in the female endocrine dyscrasia medicine that depression of liver-QI causes as preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1086131C (en) | 2002-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1186071C (en) | Medicines composition for treating chronic heart failure and its prepn | |
| CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN1265833C (en) | Chinese medicinal preparation for treating cancer | |
| CN1404853A (en) | Medicine for treating tonsillitis and laryngopharyngitis | |
| CN1157166A (en) | Xuefukang medicine | |
| CN1246354A (en) | Medicinal composition for treating hyperplasia of mammary gland disease | |
| CN1172690C (en) | Chinese medicine powder for treating tetanic rachitis | |
| CN1304769A (en) | Blood-cleaning pill | |
| CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN1895513A (en) | Medicine for treating oral lichen planus | |
| CN1051017C (en) | Thrombus dissolving Guiluchun | |
| CN101085137A (en) | Traditional Chinese medicine formula for treating rheumatoid oarthritis | |
| CN1907353A (en) | Chinese traditional medicine preparation for treating chronic gastritis | |
| CN1059811C (en) | Complete set of Chinese medicine preparations for curing hepatitis B | |
| CN1319586C (en) | Medicinal composition for treating brain apoplexy | |
| CN1056301C (en) | 'Lanweiling' oral liquid for treating appendicitis | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN1178682C (en) | Angiocardiopathy treating traditional Chinese medicine | |
| CN1186083C (en) | Chinese medicine for treating mammary gland foliole proliferation | |
| CN1057696C (en) | Chinese drug composition for curing gastritis and other stomachache | |
| CN110624087A (en) | Traditional Chinese medicine composition for soothing liver-qi stagnation and preparation and application thereof | |
| CN1186060C (en) | Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method | |
| CN1186038C (en) | Capsule for curing aplastic anemia and its production method | |
| CN1081065C (en) | Compound oral liquid of cactus | |
| CN1255149C (en) | Combination of medication |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |